ADMA BIOLOGICS, INC. Sales Returns, Goods (Deprecated 2018-01-31)
ADMA BIOLOGICS, INC. (ADMA) reported Sales Returns, Goods (Deprecated 2018-01-31) of $3.36 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Income Statement › Other Income
us-gaap:SalesReturnsGoods · last filed 2017-08-11
- ADMA BIOLOGICS, INC. sales returns, goods (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $3.36M, a 50.43% increase year-over-year.
- ADMA BIOLOGICS, INC. sales returns, goods (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $2.59M, a 24.18% increase year-over-year.
- ADMA BIOLOGICS, INC. sales returns, goods (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $2.90M, a 59.35% increase year-over-year.
- ADMA BIOLOGICS, INC. sales returns, goods (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $2.24M, a 73.20% increase year-over-year.
| Period end | Sales Returns, Goods (Deprecated 2018-01-31) 3 month | Sales Returns, Goods (Deprecated 2018-01-31) 6 month | Sales Returns, Goods (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2017-06-30 | $3.36M 10-Q · filed 2017-08-11 | $5.96M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $2.59M 10-Q · filed 2017-05-12 | ||
| 2016-09-30 | $2.90M 10-Q · filed 2016-11-10 | $5.14M derived: sum of 2 quarters · filed 2017-08-11 | $7.23M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.24M 10-Q · filed 2017-08-11 | $4.32M 10-Q · filed 2017-08-11 | |
| 2016-03-31 | $2.09M 10-Q · filed 2017-05-12 | ||
| 2015-09-30 | $1.82M 10-Q · filed 2016-11-10 | $3.11M derived: sum of 2 quarters · filed 2016-11-10 | $4.60M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $1.29M 10-Q · filed 2016-08-12 | $2.78M 10-Q · filed 2016-08-12 | |
| 2015-03-31 | $1.48M 10-Q · filed 2016-05-13 | ||
| 2014-09-30 | $1.35M 10-Q · filed 2015-11-10 | $2.83M derived: sum of 2 quarters · filed 2015-11-10 | $4.37M 10-Q · filed 2015-11-10 |
| 2014-06-30 | $1.48M 10-Q · filed 2015-08-11 | $3.02M 10-Q · filed 2015-08-11 | |
| 2014-03-31 | $1.54M 10-Q · filed 2015-05-12 | ||
| 2013-09-30 | $1.09M 10-Q · filed 2014-11-10 | $1.83M derived: sum of 2 quarters · filed 2014-11-10 | $2.62M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $736.97K 10-Q · filed 2014-08-11 | $1.53M 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |